This fact might be related to the different subpopulation patterns of surface CXCL12 receptors in this BC cell line (with higher proportion of CXCR4+-only cells) and/or to the lower levels of basal ERK1/2 activation status, thus allowing a more dynamic activation range [33]. This evidence concerns the gene MAPK3 and breast cancer.